NasdaqGM:HIIQ

Stock Analysis Report

Health Insurance Innovations

Executive Summary

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States.

Snowflake

Fundamentals

High growth potential and slightly overvalued.

Risks

  • Health Insurance Innovations has significant price volatility in the past 3 months.

Share Price & News

How has Health Insurance Innovations's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

15.8%

HIIQ

0.9%

US Insurance

-0.2%

US Market


1 Year Return

-60.4%

HIIQ

8.2%

US Insurance

1.1%

US Market

HIIQ underperformed the Insurance industry which returned 9.2% over the past year.

HIIQ underperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

HIIQIndustryMarket
7 Day15.8%0.9%-0.2%
30 Day14.1%3.4%2.5%
90 Day-12.9%1.9%1.6%
1 Year-60.4%-60.4%10.8%8.2%3.4%1.1%
3 Year305.0%305.0%47.3%36.0%45.2%35.8%
5 Year110.6%110.6%72.1%51.6%62.6%44.8%

Price Volatility Vs. Market

How volatile is Health Insurance Innovations's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Health Insurance Innovations undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Health Insurance Innovations's share price is below the future cash flow value, and at a moderate discount (> 20%).

Health Insurance Innovations's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Health Insurance Innovations is overvalued based on earnings compared to the US Insurance industry average.

Health Insurance Innovations is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Health Insurance Innovations is poor value based on expected growth next year.


Price Based on Value of Assets

Health Insurance Innovations is overvalued based on assets compared to the US Insurance industry average.


Next Steps

Future Growth

How is Health Insurance Innovations expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

21.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Health Insurance Innovations's revenue is expected to grow by 11.4% yearly, however this is not considered high growth (20% yearly).

Health Insurance Innovations's earnings are expected to grow significantly at over 20% yearly.

Health Insurance Innovations's revenue growth is expected to exceed the United States of America market average.

Health Insurance Innovations's earnings growth is expected to exceed the United States of America market average.

Health Insurance Innovations's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Health Insurance Innovations is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).


Next Steps

Past Performance

How has Health Insurance Innovations performed over the past 5 years?

50.1%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Health Insurance Innovations has delivered over 20% year on year earnings growth in the past 5 years.

Health Insurance Innovations's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Health Insurance Innovations's 1-year earnings growth is negative, it can't be compared to the US Insurance industry average.


Return on Equity

Health Insurance Innovations has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Health Insurance Innovations used its assets less efficiently than the US Insurance industry average last year based on Return on Assets.


Return on Capital Employed

Health Insurance Innovations's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Health Insurance Innovations's financial position?


Financial Position Analysis

Health Insurance Innovations is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Health Insurance Innovations's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Health Insurance Innovations's level of debt (152.1%) compared to net worth is high (greater than 40%).

Unable to establish if Health Insurance Innovations's debt level has increased without past 5-year debt data.

Operating cash flow is negative therefore debt is not well covered.

Interest payments on debt are well covered by earnings (EBIT is 16.6x coverage).


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 1.5x debt.


Next Steps

Dividend

What is Health Insurance Innovations's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Health Insurance Innovations's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Health Insurance Innovations's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Health Insurance Innovations has not reported any payouts.

Unable to verify if Health Insurance Innovations's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Health Insurance Innovations has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Health Insurance Innovations's salary, the management and board of directors tenure and is there insider trading?

3.3yrs

Average management tenure


CEO

Gavin Southwell (41yo)

2.8yrs

Tenure

US$2,238,600

Compensation

Mr. Gavin Southwell has been Chief Executive Officer of Health Insurance Innovations, Inc. since November 15, 2016 and has been its President since July 2016. Mr. Southwell served as a Consultant of Healt ...


CEO Compensation Analysis

Gavin's remuneration is higher than average for companies of similar size in United States of America.

Gavin's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

3.3yrs

Average Tenure

54yo

Average Age

The tenure for the Health Insurance Innovations management team is about average.


Board Age and Tenure

2.8yrs

Average Tenure

57.5yo

Average Age

The average tenure for the Health Insurance Innovations board of directors is less than 3 years, this suggests a new board.


Insider Trading

Health Insurance Innovations individual insiders have only sold shares in the past 3 months.


Recent Insider Transactions

SellUS$15,50510 Jul 19
Michael Kosloske
EntityIndividual
Shares620
Max PriceUS$25.02
SellUS$1,312,88710 Jul 19
Michael Kosloske
EntityIndividual
Shares51,906
Max PriceUS$26.04
SellUS$2,021,51808 Jul 19
Michael Kosloske
EntityIndividual
Shares77,211
Max PriceUS$26.50
SellUS$1,346,45103 Jul 19
Michael Kosloske
EntityIndividual
Shares51,160
Max PriceUS$26.72
SellUS$1,059,28901 Jul 19
Michael Kosloske
EntityIndividual
Shares41,393
Max PriceUS$25.61
SellUS$2,749,02426 Jun 19
Michael Kosloske
EntityIndividual
Shares105,401
Max PriceUS$26.21
BuyUS$7,862,74317 Apr 19
Cannell Capital LLC
EntityCompany
Shares203,698
Max PriceUS$38.60
BuyUS$459,51910 Apr 19
Paul Gabos
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares15,000
Max PriceUS$30.63
BuyUS$89,06125 Mar 19
Paul Avery
EntityIndividual
Role
Member of the Board of Directors
Director
Shares3,000
Max PriceUS$29.69
BuyUS$2,655,66420 Mar 19
B. Riley Capital Management, LLC
EntityCompany
Shares90,742
Max PriceUS$29.27
BuyUS$89,51320 Mar 19
John Fichthorn
EntityIndividual
Role
Member of the Board of Directors
Director
Shares3,000
Max PriceUS$29.84
BuyUS$239,25420 Mar 19
Paul Gabos
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman
Shares8,000
Max PriceUS$29.91
BuyUS$17,746,21627 Dec 18
Cannell Capital LLC
EntityCompany
Shares386,197
Max PriceUS$45.95
SellUS$5,074,81627 Dec 18
Cannell Capital LLC
EntityCompany
Shares103,119
Max PriceUS$49.21
BuyUS$200,51018 Dec 18
Robert Murley
EntityIndividual
Role
Member of the Board of Directors
Director
Shares6,500
Max PriceUS$30.85

Ownership Breakdown


Management Team

  • Jeffrey Eisenberg (54yo)

    Consultant

    • Tenure: 4.9yrs
    • Compensation: US$10.00k
  • Gavin Southwell (41yo)

    President

    • Tenure: 2.8yrs
    • Compensation: US$2.24m
  • Mike Hershberger (56yo)

    CFO, Treasurer & Secretary

    • Tenure: 4.5yrs
    • Compensation: US$815.40k
  • Gerod Vernon

    Vice President of Sales

    • Tenure: 0yrs
  • Angela Bryant

    Senior VP & General Counsel

    • Tenure: 0yrs
  • Domenick DiCicco

    Chief Compliance Officer Counsel

    • Tenure: 0.3yrs
  • John Evans

    Investor Relations contact

    • Tenure: 3.7yrs
  • Mike DeVries

    Senior Vice President of Finance

    • Tenure: 0yrs
  • Jennifer Hammer

    Head of Strategic Initiatives Team

    • Tenure: 0.8yrs

Board Members

  • Paul Gabos (53yo)

    Non-Executive Chairman

    • Tenure: 2.8yrs
    • Compensation: US$191.50k
  • Paul Avery (59yo)

    Director

    • Tenure: 6.6yrs
    • Compensation: US$137.50k
  • Bob Murley (69yo)

    Director

    • Tenure: 4.9yrs
    • Compensation: US$137.50k
  • Peggy Scott (68yo)

    Independent Director

    • Tenure: 0.3yrs
  • John Fichthorn (46yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$130.00k
  • Gavin Southwell (41yo)

    President

    • Tenure: 2.8yrs
    • Compensation: US$2.24m
  • Anthony Barkett (72yo)

    Director

    • Tenure: 6.5yrs
    • Compensation: US$151.50k
  • Ellen Duffield (56yo)

    Independent Director

    • Tenure: 0.3yrs

Company Information

Health Insurance Innovations, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Health Insurance Innovations, Inc.
  • Ticker: HIIQ
  • Exchange: NasdaqGM
  • Founded: 2008
  • Industry: Insurance Brokers
  • Sector: Insurance
  • Implied Market Cap: US$295.543m
  • Market Cap: US$278.658m
  • Shares outstanding: 14.18m
  • Website: https://www.hiiq.com

Number of Employees


Location

  • Health Insurance Innovations, Inc.
  • 15438 North Florida Avenue
  • Suite 201
  • Tampa
  • Florida
  • 33613
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
HIIQNasdaqGM (Nasdaq Global Market)YesClass A Common StockUSUSDFeb 2013
6LNDB (Deutsche Boerse AG)YesClass A Common StockDEEURFeb 2013
0J3ULSE (London Stock Exchange)YesClass A Common StockGBUSDFeb 2013

Biography

Health Insurance Innovations, Inc. operates as a cloud-based technology platform and distributor of individual and family health insurance plans, and supplemental products in the United States. It offers s ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:07
End of Day Share Price2019/09/19 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.